|
1 |
23 03 2026 |
Pharmexcil seeks urgent industry data as West Asia crisis hits pharma exports |
Pharmabiz |
India |
|
2 |
23 03 2026 |
Commerce ministry seeks exporters inputs to tackle trade barriers with Australia & New Zealand |
Pharmabiz |
India |
|
3 |
23 03 2026 |
RCA affirms commitment to transparent pharmaceutical trade ecosystem in Rajasthan |
Pharmabiz |
India |
|
4 |
23 03 2026 |
India emerging as strong pharma economy,says Jitendra Singh |
Telangana Today |
India |
|
5 |
23 03 2026 |
Government panel drops Plan to Ban Ads on Schedule G drugs, cites Alternative |
Medical Dialogues |
India |
|
6 |
23 03 2026 |
CDSCO flags illegal manufacturing of Sodium Hyaluronate Eye drops seeks immediate action |
Medical Dialogues |
India |
|
7 |
23 03 2026 |
CDSCO panel recommends key changes in Phase III study of Glimepiride - Linagliptin FDC |
Medical Dialogues |
India |
|
8 |
21 03 2026 |
Over 9000 serious adverse events reported in India clinical trails in 5 years: Government Data |
Medical Dialogues |
India |
|
9 |
21 03 2026 |
Mankind Pharma acquires Rivotril brands from Roche to boost CNS portfolio in India |
Medical Dialogues |
India |
|
10 |
21 03 2026 |
Semaglutide patent expiry sparks generic rush in India, prices set to drop sharply |
Medical Dialogues |
India |
|
11 |
21 03 2026 |
CDSCO delegates Veterinary drug licensing powers to Zonal offices to ease approvals |
Medical Dialogues |
India |
|
12 |
21 03 2026 |
HDMA seeks Centre's intervention to address issues arising from West Asia crisis |
Pharmabiz |
India |
|
13 |
21 03 2026 |
Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes |
Pharmabiz |
India |
|
14 |
21 03 2026 |
New PRIME tools to accelerate development of medicines in the EU |
Pharmabiz |
India |
|
15 |
21 03 2026 |
Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India |
Pharmabiz |
India |
|
16 |
21 03 2026 |
Eris launches weekly shot of Semaglutide starting at ₹220 per shot |
Express Pharma |
India |
|
17 |
21 03 2026 |
Domestic pharma market seen touching $130 billion by 2030 |
DD NEWS |
India |
|
18 |
21 03 2026 |
MSME Phrama units warn of shutdown risk amid cost surge,delayed payments |
Times of India |
India |
|
19 |
20 03 2026 |
CDSCO asks all SLAs to adopt guidance document for uniform product licensing |
Pharmabiz |
India |
|
20 |
20 03 2026 |
Authentication solutions emerge as pharma industry’s strongest shield against counterfeits at TAF Connect 2026 |
Pharmabiz |
India |
